Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.

Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Van Deerlin VM, Lee VM, Soares H, Trojanowski JQ.

Ann Neurol. 2011 Apr;69(4):655-63. doi: 10.1002/ana.22271. Epub 2010 Nov 29.

2.

Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.

Pellecchia MT, Santangelo G, Picillo M, Pivonello R, Longo K, Pivonello C, Vitale C, Amboni M, De Rosa A, Moccia M, Erro R, De Michele G, Santoro L, Colao A, Barone P.

J Neurol. 2013 Feb;260(2):438-44. doi: 10.1007/s00415-012-6648-6. Epub 2012 Aug 22.

PMID:
22911513
3.

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C.

Neurology. 2010 Sep 21;75(12):1055-61. doi: 10.1212/WNL.0b013e3181f39a78. Epub 2010 Aug 18.

4.

Genetic influences on cognitive decline in Parkinson's disease.

Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A.

Mov Disord. 2012 Apr;27(4):512-8. doi: 10.1002/mds.24946. Epub 2012 Feb 16.

5.

Uric acid and cognition in Parkinson's disease: a follow-up study.

Annanmaki T, Pohja M, Parviainen T, Hakkinen P, Murros K.

Parkinsonism Relat Disord. 2011 Jun;17(5):333-7. doi: 10.1016/j.parkreldis.2011.01.013. Epub 2011 Feb 12.

PMID:
21320793
6.

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.

Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A; PARS Investigators; Alzheimer's Disease Neuroimaging Initiative, Trojanowski JQ, Chen-Plotkin AS.

Ann Clin Transl Neurol. 2016 Mar 29;3(5):346-55. doi: 10.1002/acn3.299. eCollection 2016 May.

7.

Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.

Rocha NP, Teixeira AL, Scalzo PL, Barbosa IG, de Sousa MS, Morato IB, Vieira EL, Christo PP, Palotás A, Reis HJ.

Mov Disord. 2014 Apr;29(4):527-31. doi: 10.1002/mds.25752. Epub 2013 Dec 3.

PMID:
24301904
8.

Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.

Ng A, Chander RJ, Tan LC, Kandiah N.

Parkinsonism Relat Disord. 2015 Sep;21(9):1056-60. doi: 10.1016/j.parkreldis.2015.06.014. Epub 2015 Jun 18.

PMID:
26117438
9.

Plasma apolipoprotein A1 as a biomarker for Parkinson disease.

Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, Chen-Plotkin AS.

Ann Neurol. 2013 Jul;74(1):119-27. doi: 10.1002/ana.23872. Epub 2013 Aug 6.

10.

Quantitative EEG as a predictive biomarker for Parkinson disease dementia.

Klassen BT, Hentz JG, Shill HA, Driver-Dunckley E, Evidente VG, Sabbagh MN, Adler CH, Caviness JN.

Neurology. 2011 Jul 12;77(2):118-24. doi: 10.1212/WNL.0b013e318224af8d. Epub 2011 Jun 1.

11.

Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.

Umemura A, Oeda T, Yamamoto K, Tomita S, Kohsaka M, Park K, Sugiyama H, Sawada H.

PLoS One. 2015 Aug 26;10(8):e0136722. doi: 10.1371/journal.pone.0136722. eCollection 2015.

12.

Cognitive status correlates with neuropathologic stage in Parkinson disease.

Braak H, Rüb U, Jansen Steur EN, Del Tredici K, de Vos RA.

Neurology. 2005 Apr 26;64(8):1404-10.

PMID:
15851731
13.

Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.

Kandiah N, Zhang A, Cenina AR, Au WL, Nadkarni N, Tan LC.

Parkinsonism Relat Disord. 2014 Nov;20(11):1145-8. doi: 10.1016/j.parkreldis.2014.08.002. Epub 2014 Aug 14.

PMID:
25176439
14.

Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

Rodriguez-Oroz MC, Lage PM, Sanchez-Mut J, Lamet I, Pagonabarraga J, Toledo JB, García-Garcia D, Clavero P, Samaranch L, Irurzun C, Matsubara JM, Irigoien J, Bescos E, Kulisevsky J, Pérez-Tur J, Obeso JA.

Mov Disord. 2009 Jul 30;24(10):1437-44. doi: 10.1002/mds.22522.

PMID:
19452554
15.

Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.

Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH.

J Parkinsons Dis. 2015;5(1):117-24. doi: 10.3233/JPD-140480.

PMID:
25420672
16.

Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

Picillo M, Pivonello R, Santangelo G, Pivonello C, Savastano R, Auriemma R, Amboni M, Scannapieco S, Pierro A, Colao A, Barone P, Pellecchia MT.

PLoS One. 2017 Oct 24;12(10):e0186508. doi: 10.1371/journal.pone.0186508. eCollection 2017.

17.

Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.

Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G.

Mov Disord. 2015 Apr 15;30(5):696-704. doi: 10.1002/mds.26160. Epub 2015 Mar 11.

PMID:
25757654
18.

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.

Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bottiglieri T.

Neurology. 2005 Nov 8;65(9):1402-8.

PMID:
16275827
19.

Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).

Sánchez-Ferro Á, Benito-León J, Louis ED, Mitchell AJ, Molina-Arjona JA, Trincado R, Villarejo A, Bermejo-Pareja F.

Mov Disord. 2013 Feb;28(2):161-8. doi: 10.1002/mds.25148. Epub 2012 Dec 12.

PMID:
23239285
20.

Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.

Pellecchia MT, Santangelo G, Picillo M, Pivonello R, Longo K, Pivonello C, Vitale C, Amboni M, De Rosa A, Moccia M, Erro R, De Michele G, Santoro L, Colao A, Barone P.

Eur J Neurol. 2014 May;21(5):802-7. doi: 10.1111/ene.12137. Epub 2013 Mar 29.

PMID:
23551560

Supplemental Content

Support Center